We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Industry

Image: The combined offering is designed to streamline workflows and support multicolor applications used in leukemia, lymphoma, and measurable residual disease assessment in specialized clinical settings

Sysmex and Cytek Collaboration Expands Access to Advanced Clinical Flow Cytometry

Sysmex Europe and Cytek Biosciences are partnering across more than a dozen European countries to expand advanced clinical flow cytometry access. More...
10 Sep 2026
Image: PixCell Medical’s HemoScreen POC hematology analyzer combines AI-powered digital imaging with Viscoelastic Focusing technology to deliver lab-quality 5-part differential CBC results (Photo courtesy of PixCell Medical)

Health Canada Licenses Point-of-Care Hematology Analyzer for Decentralized CBC Testing

PixCell Medical’s HemoScreen point‑of‑care hematology analyzer receives a Health Canada Class III Medical Device License. More...
10 Sep 2026
Image: The latest FDA approval expands the Guardant360 CDx platform to 29 companion diagnostic indications globally (Photo courtesy of Guardant Health)

FDA Clears Liquid Biopsy Test to Guide Earlier Breast Cancer Therapy Switch

Guardant360 CDx was FDA-approved to identify ESR1 mutations and guide camizestrant use in HR+/HER2- breast cancer. More...
05 Sep 2026
Image: The collaboration between Heidelberg Epignostix and the NHS Genomic Medicine Service (GMS) establishes a national framework spanning each of the NHS GMS Genomic Laboratory testing service. (Image Credit: Heidelberg Epignostix)

New NHS Partnership Expands Access to Epigenetic CNS Tumor Classifiers

A new partnership now brings clinically validated epigenetic tumor classifiers into NHS genomic laboratory services across England.  More...
02 Sep 2026
Image: The Lumipulse G NfL Blood assay provides a reliable method for the quantitative measurement of neurofilament light chain NfL in serum and plasma (Photo courtesy of Fujirebio)

Fujirebio Expands Access to Automated Blood-Based Neurology Testing in Canada

Health Canada has issued Class II Medical Device Licenses for Lumipulse G NfL Blood and Lumipulse G pTau 217 Plasma on the fully automated LUMIPULSE G platform. More...
02 Sep 2026
Image:  About 14.2 million Americans are eligible for annual lung cancer screening, but uptake remains low and LDCT false positives persist; CIZ1B may improve risk stratification and reduce uncertainty (Image Credit: Adobe Stock)

Validated Biomarker Blood Test Detects Early Lung Cancer and Supports Risk Assessment

Cizzle Bio’s CIZ1B ELISA biomarker test detects an early lung cancer-linked protein variant, complementing low-dose CT to clarify indeterminate findings. More...
01 Sep 2026
Image: Natera’s Signatera test will be used in a partnership with Angiex to evaluate patients receiving AGX101, a Nuclear-Delivered Antibody-Drug Conjugate (ND-ADC) in a Phase I clinical trial.

Natera ctDNA Test to Support Response Monitoring in Solid Tumor Trial

Natera’s Signatera test will be used to evaluate patients receiving Angiex’s nuclear-delivered antibody-drug conjugate in a Phase I trial. More...
31 Aug 2026
Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
New
Drug Testing Assays
Atellica DT 250 Analyzer


LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.
Copyright © 2000-2026 Globetech Media. All rights reserved.